Heterotypic inhibition of foot-and-mouth disease virus infection by combinations of RNA transcripts corresponding to the 5' and 3' regions

Antiviral Research

Volumn 44, Issue 2, 1999, Pages 133-141

  Bigeriego, Paloma ^a,b   Rosas, Maria Flora ^b   Zamora, Eva ^b   Martínez Salas, Encarnación ^a   Sobrino, Francisco ^a,b  

^a CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^b INIA   (Spain)

Author keywords

FMDV; Genetic variability; Heterotypic; Transcripts combination; Viral inhibition

Indexed keywords

COMPLEMENTARY RNA; VIRUS RNA;

ANIMAL CELL; ARTICLE; CELL STRAIN BHK; CONTROLLED STUDY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA TRANSCRIPTION; SEROTYPE; VIRUS GENE; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS PARTICLE;

ANIMALS; APHTHOVIRUS; CELLS, CULTURED; CRICETINAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, ANTISENSE; SEROTYPING; TRANSFECTION;

ANIMALIA; DNA VIRUSES; FOOT-AND-MOUTH DISEASE VIRUS; PICORNAVIRIDAE; RNA VIRUSES; SUS SCROFA; SWINE VESICULAR DISEASE VIRUS;

EID: 0032793388     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(99)00057-1     Document Type: Article

References (41)

1. Agrawal S. Antisense oligonucleotides as antiviral agents. TIBTECH. 10:1992;152-158.
2. Arlinghaus R.B., Polatnick J. The isolation of two enzyme-ribonucleic acid complexes involved in the synthesis of foot-and-mouth disease virus ribonucleic acid. Proc. Natl. Acad. Sci. USA. 26:1969;821-829.
3. Bachrach H.L. Foot-and-mouth disease virus. Annu. Rev. Microbiol. 22:1968;201-244.
4. Barteling S.J., Vreeswijk J. Developments in foot-and-mouth disease vaccines. Vaccine. 9:1991;75-88.
5. Barteling S.J., Woortmeyer R. Multiple variants in foot-and-mouth disease virus (FMDV) populations: the Achilles heel for peptide and rec. DNA vaccines? Dev. Biol. Stand. 66:1987;511-520.
6. Beck E., Feil G., Strohmaier K. The molecular basis of antigenic variation of foot-and-mouth disease virus. EMBO J. 2:1983;555-559.
7. Beck E., Forss S., Strebel K., Cattaneo R., Feil G. Structure of the FMDV translation initiation site and of the structural proteins. Nucleic Acids Res. 11:1983;7873-7885.
8. Belsham G.J., Brangwyn J.K. A region of the 5′ noncoding region of foot-and-mouth disease virus RNA directs efficient internal initiation of protein synthesis within cells: involvement with the role of L protease in translational control. J. Virol. 64:1990;5389-5395.
9. Bischofberger N., Wagner R.W. Antisense approaches to antiviral agents. Semin. Virol. 3:1992;57-66.
10. Cohen J.S. Antisense oligodeoxynucleotides as antiviral agents. Antiviral Res. 16:1991;121-133.
11. de Wet J.R., Wood K.V., DeLuca M., Helinski D.R., Subramani S. Firefly luciferase yen: structure and expression in mammalian cells. Mol. Cell. Biol. 7:1987;725-737.
12. Domingo E., Escarmís C., Martínez M.A., Martínez-Salas E., Mateu M.G. Foot-and-mouth disease virus populations are quasispecies. Curr. Top. Microbiol. Immunol. 176:1992;33-47.
13. Domingo E., Holland J.J. Complications of the RNA heterogeneity for the engineering of virus vaccines and antiviral agents. Setlow J.K. Genetic Engineering, Principles and Methods, vol 14. 1992;13-32 Plenum, New York.
14. Domingo E., Mateu G., Martínez M.A., Dopazo J., Moya A., Sobrino F. Genetic variability and antigenic diversity of foot- and-mouth disease virus. Kurstak E., Marusyk R.G., Murphy S.A., Van Regenmortel M.H.V. Applied Virology Research, Virus Variation and Epidemiology. II:1990;233-266 Plenum, New York.
15. Forss S., Strebel K., Beck E., Schaller H. Nucleotide sequence and genome organization of FMDV. Nucleic Acids Res. 12:1984;6587-6601.
16. Graessmann M., Graessmann A. The biological activity of early SV40 antisense RNA and DNA molecules. Curr. Top. Microbiol. Immunol. 44:1989;97-103.
17. Gutiérrez A., Martínez-Salas E., Pintado B., Sobrino F. Specific inhibition of aphthovirus infection by RNAs transcribed from both 5′ and 3′ noncoding regions. J. Virol. 68:1994;7426-7432.
18. Gutiérrez A., Rodríguez A., Pintado B., Sobrino F. Transient inhibition of foot-and-mouth disease virus infection of BHK-21 cells by antisense oligonucleotides directed against the second functional initiator AUG. Antiviral Res. 22:1993;1-13.
19. Hanecak R., Brown-Driver V., Fox M.C., Azad R.F., Furusako S., Nozaki C., Ford C., Sasmor H., Anderson K.P. Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes. J. Virol. 70:1996;5203-5212.
20. Helené C., Toulmé J.J. Specific regulation of gene expression by antisense, sense and antisense nucleic acids. Biochim. Biophys. Acta. 1049:1990;99-125.
21. Kim S.G., Hatta T., Tsukahara S., Nakashima H., Yamamoto N., Shoji Y., Takai K., Takaku H. Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus. Bioorg. Med. Chem. 3:1995;49-54.
22. Knowles N.J., Sellers R.F. Swine vesicular disease. Beran G.W. Handbook of Zoonoses, Section B: Viral. 2nd edn:1994;437-444 CRC Press, Boca Raton, FL.
23. Kühn R., Luz N., Beck E. Functional analysis of the internal translation initiation site of foot-and-mouth disease virus. J. Virol. 64:1990;4625-4631.
24. Martínez-Salas E., Domingo E. Effect of expression of the aphthovirus protease 3C on viral infection and gene expression. Virology. 212:1995;111-120.
25. Martínez-Salas E., Ortín J., Domingo E. Sequence of the viral replicase gene from foot-and-mouth disease virus C1-Santa Pau (C-S8). Gene. 35:1985;55-61.
26. Martínez-Salas E., Sáiz J.C., Dávila M., Belsham G.J., Domingo E. A single nucleotide substitution in the internal ribosome entry site of foot-and mouth disease virus leads to enhanced cap-independent translation in vivo. J. Virol. 67:1993;3748-3755.
27. Mellits K.H., Meredith J.M., Rohll J.B., Evans D.J, Almond J.W. Binding of a cellular factor to the 3′ untranslated region of the RNA genomes of entero and rhinoviruses plays a role in virus replication. J. Gen. Virol. 79:1998;1715-1723.
28. Mizutani T., Hayashi M., Maeda A., Sasaki N., Yamashita T., Kasai N., Namioka S. Inhibition of mouse hepatitis virus multiplication by antisense oligonucleotide, antisense RNA, sense RNA and ribozyme. Adv. Exp. Med. Biol. 342:1993;129-135.
29. Pereira H.G. Foot-and-mouth disease. Gibbs E.P.J. Virus Diseases of Food Animals. I:1981;333-363 Academic Press, London.
30. Pilipenko E.V., Blinov V.H., Chernov B.K., Dimitrieva T.M., Agol V.I. Conservation of secondary structure elements of the 5′ untranslated region of cardio and aphthovirus RNAs. Nucleic Acids Res. 17:1989;5701-5711.
31. Rohll J.B., Moon D.H., Evans D.J., Almond J.W. The 3′ untraslated region of picornavirus RNA: features required for efficient genome replication. J. Virol. 69:1995;7835-7844.
32. Rose J.K., Buonocore L., Whitt M.A. A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. Biotechniques. 10:1991;520-525.
33. Sáiz J.C., González M.J., Morgan D.O., Card J.L., Sobrino F., Moore D.M. Antigenic comparison of different foot-and-mouth disease virus types using monoclonal antibodies defining multiple neutralizing epitopes on FMDV A5 subtypes. Virus Res. 13:1989;45-60.
34. Sáiz J.C., Sobrino F., Dopazo J. Molecular evolution of foot-and-mouth disease virus type O. J. Gen. Virol. 74:1993;2281-2285.
35. Sangar D.V. The replication of picornavirus. Virology. 45:1979;1-11.
36. Seechurn P., Knowles N.J., McCauley J.W. The complete nucleotide sequence of a pathogenic swine vesicular disease virus. Virus Res. 16:1990;255-274.
37. Taboga O., Tami C., Carrillo E., Núñez J.I., Rodríguez A., Sáiz J.C., Blanco E., Valero M.L., Roig X., Camarero J.A., Andreu D., Mateu M.G., Giralt E., Domingo E., Sobrino F., Palma E.L. A large scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of scape mutants. J. Virol. 71:1997;2606-2614.
38. Todd S., Nguyen J.H., Semler B.L. RNA-protein interactions directed by the 3′ end of human rhinovirus genomic RNA. J. Virol. 69:1995;3605-3614.
39. Todd S., Semler B.L. Structure-infectivity analysis of the human rhinovirus genomic RNA 3′ non-coding region. Nucleic Acids Res. 24:1996;2133-2142.
40. Yao Z., Zhou Y., Feng X., Chen C., Guo J. In vivo inhibition of hepatitis B viral gene expression by antisense phosphorothioate oligodeoxynucleotides in athymic nude mice. J. Viral Hepat. 3:1996;19-22.
41. Yilma T. Morphogenesis of vesiculation in foot-and-mouth disease virus. Am. J. Vet. Res. 41:1980;1537-1542.